Loading data for ADIL — first visit, this takes a few seconds.
Adial Pharmaceuticals Inc... (ADIL)
NasdaqCM: ADIL
· Real-Time Price · USD
5.90
+0.15 (2.61%)
At close: Aug 20, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
Adial Pharmaceuticals Inc. (ADIL) Stock Price, Analysis & Data
2.61% (1D)
No data available
| Bid | 4.57 |
| Market Cap | 15.49M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -57.8M |
| n/a | |
| -17.71 | |
| n/a | |
| -0.79 | |
| P/B (ttm) | -0.40 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | 3.08 |
| Volume | 41,961 |
| Avg. Volume (20D) | 421,459 |
| Open | 5.81 |
| Previous Close | 5.75 |
| Day's Range | 5.36 - 5.91 |
| 52-Week Range | 1.31 - 10.75 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ADIL
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The...
Industry Biotechnology
Sector Healthcare
IPO Date Jul 27, 2018
Employees 5
Stock Exchange NasdaqCM
Ticker Symbol ADIL
Website https://www.adial.com
Financial Performance
In 2025, Adial Pharmaceuticals's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -7.98M, a decrease of -39.56%.
Financial StatementsEarnings Surprise
Adial Pharmaceuticals has released their quarterly earnings on May 8, 2026:
Page 1 of 2